Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...

Groundbreaking research shows how your sleep patterns may be silently increasing your diabetes risk, with night owls facing the highest threat.

Injectable therapies are essential for managing many chronic conditions, yet they pose significant challenges. Complex dosing regimens, fear of injections, and variability in injection technique can ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

Stock analysts at Leerink Partnrs increased their Q1 2025 earnings per share estimates for DexCom in a research report issued ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the advancement ...

The Freedom Bank of Virginia ("Freedom Bank") announced today it formed a new Advisory Board designed to provide strategic guidance, expert advice, and support to the bank's leadership team. This ...

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

Political uncertainty in some of the largest European economies has diminished their growth outlook. Read more here.

With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, ...